Sage Therapeutics (NASDAQ:SAGE) Posts Earnings Results, Meets Estimates
MarketBeatSage Therapeutics (NASDAQ:SAGE – Get Free Report) announced its earnings results on Tuesday. The biopharmaceutical company reported ($1.53) EPS for the quarter, meeting the consensus estimate of ($1.53). The company had revenue of $11.87 million during…